Adolfo Pisanu, Alberto Ravarino, Riccardo Nieddu, Alessandro Uccheddu, Department of Surgery; Department of Pathology, University of Cagliari, Clinica Chirurgica, Cagliari, Italy
Supported by grant from the University of Cagliari, Italy
Correspondence to: Dr. Adolfo Pisanu, Clinica Chirurgica, Universitą degli Studi di Cagliari, Ospedale San Giovanni di Dio, Via Ospedale 46, Cagliari 09124, Italy. firstname.lastname@example.org
Telephone: +39-70-6092420 Fax: +39-70-6092417
Received: May 11, 2007 Revised: August 3, 2007
This study aimed to describe a case in which an isolated splenic metastasis was synchronous with the colonic primary and a concomitant splenic abscess was associated. A wide review of the literature was also performed. A 54-year-old woman with abdominal pain and fever was admitted to our department. Abdominal CT revealed two low-density areas in the spleen and wall-thickening of the left colonic flexure, which was indistinguishable from the spleen parenchyma. The patient underwent emergency celiotomy, with the presumptive diagnosis of obstructing colon carcinoma of the splenic flexure, and concomitant splenic abscess. Subtotal colectomy and splenectomy were performed. Pathological findings were consistent with mucinous colonic carcinoma, synchronous isolated splenic metastasis and concomitant splenic abscess. This paper is also a review of the existing literature on the association between colorectal cancer and splenic metastasis. Only 41 cases of isolated splenic metastasis from colon carcinoma have been reported in the literature. This report is the third described case of synchronous isolated splenic metastasis from colon carcinoma. Only one case with concomitant splenic abscess has been previously reported. When obstructing left-sided colorectal cancer is suspected, careful CT examination can allow early diagnosis of splenic involvement by the tumor. The literature review suggests that there might be a significant improvement in survival following splenectomy for a metachronous isolated splenic metastasis from colon carcinoma. Prognosis for synchronous splenic metastasis seems to be related to the advanced stage of the disease. Nevertheless, no definitive conclusions can be drawn because of the small number of cases.
© 2007 WJG. All rights reserved.
Key words: Colon carcinoma; Splenic abscess; Splenic metastasis
Pisanu A, Ravarino A, Nieddu R, Uccheddu A. Synchronous isolated splenic metastasis from colon carcinoma and concomitant splenic abscess: A case report and review of the literature. World J Gastroenterol 2007; 13(41): 5516-5520
Primary and metastatic tumors of the spleen are described as unusual, excluding secondary involvement by lymphoma. Since metastatic carcinoma involving the spleen is usually a manifestation of widely disseminated disease, isolated splenic metastasis from colorectal carcinoma is not a common occurrence[1,3]. Its rareness has been hypothetically explained by several characteristics of the spleen, such as anatomical, histological and immunological features. Most cases are asymptomatic and the diagnosis is usually made by imaging studies during the diagnostic work up for colon cancer. However, a few patients become exceptionally symptomatic following spontaneous rupture of the spleen, or the presence of an associated splenic abscess[6,7].
We report the case of a synchronous isolated splenic metastasis from colonic carcinoma, with a concomitant splenic abscess, and we also review all cases of isolated splenic metastasis from colorectal cancer reported in the literature. To the best of our knowledge, only one case of splenic metastasis from colonic carcinoma associated with concomitant splenic abscess has been reported in the literature, which is an extremely rare clinical entity.
In June 2006, a 54-year-old Caucasian woman was referred to our emergency department because of abdominal pain associated with intermittent fever over 40℃, shaking and chills. She also complained of general fatigue and loss of appetite. Otherwise, her previous medical history was unremarkable. On clinical examination, the patient was pale and shocked. Blood pressure and pulse rate were 90/60 mmHg and 98/min, respectively. The abdomen was distended, with tenderness in the left hypochondrium. There was neither hepatosplenomegaly nor lymphadenopathy. Sepsis was identified both by a clear clinical picture which showed high fever and hemodynamic instability, and by positive blood culture which grew Escherichia coli and Bacteroides fragilis. Laboratory data on hospital admission were as follows: white blood cell count, 148 × 109/L; red blood cell count, 280 × 1012/L; hemoglobin, 67 g/L; thrombocyte count 383 × 109/L; fibrinogen, 5.17 g/L; albumin 23 ug/L; and carcinoembryonic antigen (CEA), 31.1 ug/L (normal range < 2.50 ug/L).
Chest X-ray revealed a left pleural effusion. Abdominal plain radiography showed intestinal obstruction with typical air fluid levels in the bowel. Abdominal ultrasonography demonstrated a hypoechoic area with unclear margins in the lower pole of the spleen, with the features of a splenic abscess. Enhanced abdominal CT revealed two low-density areas in the spleen (Figure 1) and wall-thickening of the left colonic flexure, which was indistinguishable from the spleen parenchyma (Figure 2). Echocardiography was normal and detected no vegetations. The patient was treated with fluid, intensive antibiotics and blood transfusion as initial therapy, and then she underwent an emergency operation for a presumptive diagnosis of obstructing colonic carcinoma and septic shock from a concomitant splenic abscess. On explorative celiotomy, the splenic flexure of the colon presented a mass occluding the lumen, infiltrating the entire colonic wall, and invading the lower pole of the spleen. There were neither hepatic metastases nor peritoneal dissemination. Frozen section examination of the spleen was performed after splenectomy. Frozen section showed the presence of splenic metastasis from adenocarcinoma, with a concomitant splenic abscess. A subtotal colectomy with side-to-side ileo-sigmoid anastomosis was then performed. The spleen weighed 160 g and measured 12 cm × 7 cm × 4.5 cm. On gross examination, the tumor originated from the left colonic flexure and invaded the spleen, in which it formed a fistula and an abscess in the metastatic tissue. The splenic metastasis measured 4.5 cm at its largest diameter and had a central abscess with a cavity of 2 cm. Histopathological findings were consistent with mucinous adenocarcinoma of the colon, synchronous isolated splenic metastasis from the primary colonic tumor (Figure 3), and concomitant splenic abscess, without metastatic lymph-node involvement (T4N0M1). Immunohistochemistry of both colonic carcinoma and splenic metastasis was performed using anti-CEA monoclonal antibody (Clone Ⅱ-7, Dako Corporation, Carpinteria, CA, USA). Staining of CEA along the luminal border of tumor cells was demonstrated both in the colonic carcinoma and in the metastasis that infiltrated the splenic pulp (Figure 4). Left pleural effusion persisted for 10 d after the operation, and the patient was finally discharged on postoperative day 15.
After 1 mo, the CEA level dropped to 3.0g/L. The patient was treated with adjuvant chemotherapy. Six months after the operation, CEA level was 10.4 g/L. Abdominal CT and positron emission tomography (PET) revealed a solitary liver metastasis of 2 cm, which was surgically removed. Exploration of the abdominal cavity revealed no further evidence of neoplastic disease. Afterward, the patient was once more subjected to adjuvant chemotherapy.
Approximately 20% of colorectal carcinomas are metastatic at their clinical presentation. Metastases to other sites in the absence of liver, lung or axial skeleton involvement are very rare[1,9]. Similar to the results of an autopsy study by Berge, microscopic splenic metastases were found in 7%-34% of cancer patients. The same author reported the incidence of splenic micrometastases arising from colorectal carcinoma to be as high as 2% in 1019 colorectal tumors, but all of these involved other organs as well. In 1969 Dunbar et al published the first case report of isolated splenic metastasis from colorectal carcinoma and to date, only 41 such cases have been reported in the literature (Table 1). All but two of previously described cases of solitary splenic metastases from colon carcinoma had a metachronous metastasis (Table 1). We have described the third reported case in which an isolated splenic lesion was synchronous with colonic carcinoma[7,11]. The particularly interesting aspect of our case was also related to the simultaneous presence of a splenic abscess, because the only other reported case with similar clinical and pathological features is that by Paramelle et al.
The rareness of splenic metastasis arising from colonic carcinoma suggests the existence of some mechanism that prohibits tumor cell proliferation in the spleen. Anatomical and immunological characteristics may be reasons for the rarity of isolated splenic metastasis. From an anatomical perspective, the sharp angle of the splenic artery with the celiac axis and rhythmic contraction by the sinusoidal splenic architecture are limiting factors for metastasis[4,12]. According to Indudhara et al, neoplastic cells can reach the splenic vein and parenchyma by retrograde diffusion through the inferior mesenteric vein. The spleen parenchyma contains no afferent lymphatic vessels, but they are present in the capsular, subcapsular and trabecular regions. Tumor cells might also reach the spleen via the lymphatic system, which explains the typical subcapsular localization of isolated splenic metastases. As the spleen is the second largest organ of the reticuloendothelial system, immune surveillance appears to potently inhibit tumor cell proliferation. Moreover, experimental studies have shown that the growth rate of adenocarcinoma cells injected into the spleen is significantly lower than that of the same cells injected into the liver.
findings in our case were consistent with mucinous adenocarcinoma of
the colon, as in three other cases of isolated splenic metastasis[3,16,17].
Mucinous gastrointestinal malignancies are thought to cause
perforation and infiltration of the full thickness of the bowel
wall, which lead to extensive invasion of the pericolic fat[3,16].
A new mechanism has been proposed in the case of contiguous splenic
metastasis from mucinous colonic tumors. Cabanas et al
have suggested that mucus-producing epithelial cells become trapped
within the trabecula of the splenic capsule, in congenital clefts of
the spleen, or in microfissures caused by trauma. The resistance of
the splenic capsule or fibrous tissue surrounding the spleen causes
the mucinous tumor to expand into the soft splenic parenchyma,
rather than the peritoneal cavity. Following the more
aggressive behavior of mucinous colonic tumors, this mechanism may
have explained the presence of the synchronous splenic metastasis in
our case. Furthermore, since CEA appears as an immunosuppressant,
and acts as an adhesion molecule between tumor cells and visceral
macrophages, colonic tumor cells with positive CEA staining should
display more aggressive behavior[4,18]. In regard to
these biological functions, CEA expression might be associated with
the occurrence of isolated splenic metastasis
The diagnosis of isolated splenic metastasis is generally made by imaging studies during the diagnostic work up for colonic cancer. Only a few patients with splenic metastasis become symptomatic because of the presence of an associated splenic abscess or spontaneous rupture of the spleen[6,19], as in our case. Okuyama et al have pointed out that only six of 28 reported patients were symptomatic at the time of diagnosis. Our patient became symptomatic as a result of abdominal occlusion and sepsis originating from the splenic abscess, in which E. coli and B. fragilis grew, as in most cases of colonic abscess associated with colonic cancer. The association between splenic abscess and colonic cancer is a very rare clinical entity, as is isolated splenic metastasis. Only a few cases have been reported in the literature, and sometimes the splenic abscess resulted from a direct fistula of descending colon carcinoma, without spleen metastasis. The most frequent complication of splenic abscess is its rupture into the peritoneal cavity, and untreated splenic abscesses have a high mortality rate.
Most previously described patients with solitary splenic metastasis from colon carcinoma had a disease-free survival of 3-144 mo after the primary tumor[11,17,24]. Long-term survival after splenectomy in patients with isolated metachronous splenic metastasis from colon carcinoma varied from 0.5 to 7 years[11,20,24]. As a result, prognosis of isolated splenic metastasis after splenectomy appears to be rather optimistic, despite the fact that splenic metastasis is one form of distant metastasis. In our case of synchronous metastasis, intensive follow-up revealed a solitary liver metastasis 6 mo after operation, without further evidence of neoplastic disease in the abdominal cavity. However, the disease-free interval after splenectomy in the case of synchronous splenic metastasis reported by Avesani et al was 10 mo, and the patients died of diffuse carcinomatosis after 1 year.
The spleen is considered unfavorable to the development of metastases but the reason for this is not clearly understood. An isolated splenic metastasis from colon carcinoma is a rare clinical finding. On the basis of the present case, when an obstructing left-sided colorectal cancer is suspected in emergency setting, careful examination of the abdominal CT-scan can allow early diagnosis of a splenic involvement by the tumor. Clinicians must pay close attention to the spleen for the early diagnosis of isolated splenic metastasis when routinely evaluating abdominal CT-scan and abdominal ultrasonography following curative resection of primary colorectal cancer. Splenectomy is necessary in the presence of isolated metastases from colon carcinoma both synchronous and methacronous. The occurrence of a splenic abscess makes emergency splenectomy mandatory as the most frequent complication is its rupture into the peritoneal cavity.
Splenectomy followed by chemotherapy seems to be the preferred treatment of isolated splenic metastases from colorectal carcinoma. There are few data available about recurrence after splenectomy for metastases of this type. Literature review suggests that there might be a significant improvement of long-term survival following splenectomy for methacronous splenic metastasis arising from colon carcinoma. Prognosis for synchronous splenic metastasis seems to be related to the advanced stage of the disease. Nevertheless, following the small number of cases reported in the literature, no definitive conclusions can be drawn.
1 Place RJ. Isolated colon cancer metastasis to the spleen. Am Surg 2001; 67: 454-457 PubMed
2 Berge T. Splenic metastases. Frequencies and patterns. Acta Pathol Microbiol Scand [A] 1974; 82: 499-506 PubMed
3 Mainprize KS, Berry AR. Solitary splenic metastasis from colorectal carcinoma. Br J Surg 1997; 84: 70 PubMed
4 Kim JC, Jeong CS, Kim HC, Yu CS, Kang GH, Lee MG. Isolated splenic metastasis from colorectal carcinoma: a case report. J Korean Med Sci 2000; 15: 355-358 PubMed
5 Gencosmanoglu R, Aker F, Kir G, Tozun N. Isolated metachronous splenic metastasis from synchronous colon cancer. World J Surg Oncol 2006; 4: 42 PubMed
6 Achuthan R, Joseph A, Haray PN. Splenic metastasis from a rectal tumour: an unusual presentation. Ann R Coll Surg Engl 1999; 81: 139 PubMed
7 Paramelle PJ, Ferretti G, Desroches E, Coulomb M. Quid? Cancer of the left colonic angle with colonic-splenic fistula, thrombosis of the splenic vein and left portal branch. J Radiol 2001; 82: 511-513 PubMed
8 Pedersen IK, Burcharth F, Roikjaer O, Baden H. Resection of liver metastases from colorectal cancer. Indications and results. Dis Colon Rectum 1994; 37: 1078-1082 PubMed
9 Klein B, Stein M, Kuten A, Steiner M, Barshalom D, Robinson E, Gal D. Splenomegaly and solitary spleen metastasis in solid tumors. Cancer 1987; 60: 100-102 PubMed
10 Dunbar WH, Beahrs OH, Morlock CG. Solitary splenic metastasis incidental to rectal carcinoma: report of a case. Mayo Clin Proc 1969; 44: 40-45 PubMed
11 Avesani EC, Cioffi U, De Simone M, Botti F, Carrara A, Ferrero S. Synchronous isolated splenic metastasis from colon carcinoma. Am J Clin Oncol 2001; 24: 311-312 PubMed
12 Cavallaro A, Modugno P, Specchia M, Pontenza AE, Loschiavo V, Colli R, Lauriola L, Barone C. Isolated splenic metastasis from colon cancer. J Exp Clin Cancer Res 2004; 23: 143-146 PubMed
13 Indudhara R, Vogt D, Levin HS, Church J. Isolated splenic metastases from colon cancer. South Med J 1997; 90: 633-636 PubMed
14 Gabizon A, Small M, Trainin N. Kinetics of the response of spleen cells from tumor-bearing animals in an in vivo tumor neutralization assay. Int J Cancer 1976; 18: 813-819 PubMed
15 Miller JN, Milton GW. An experimental comparison between tumour growth in the spleen and liver. J Pathol Bacteriol 1965; 90: 515-521 PubMed
16 Cabanas J, Gomes da Silva R, Zappa L, Esquivel J, Cerruto C, Goldstein P, Sugarbaker PH. Splenic metastases from mucinous neoplasms of the appendix and colon. Tumori 2006; 92: 104-112 PubMed
17 Genna M, Leopardi F, Valloncini E, Molfetta M, De Manzoni G, Castelli A. Metachronus splenic metastasis of colon cancer. A case report. Minerva Chir 2003; 58: 811-814 PubMed
18 Kim JC, Han MS, Lee HK, Kim WS, Park SK, Park KC, Bodmer WF, Rowan AJ, Kim OJ. Distribution of carcinoembryonic antigen and biologic behavior in colorectal carcinoma. Dis Colon Rectum 1999; 42: 640-648 PubMed
19 al-Obaidi SM. Spontaneous rupture of the spleen due to metastatic carcinoma. Br J Clin Pract 1989; 43: 385- 386 PubMed
20 Okuyama T, Oya M, Ishikawa H. Isolated splenic metastasis of sigmoid colon cancer: a case report. Jpn J Clin Oncol 2001; 31: 341-345 PubMed
21 Namavar F, Theunissen EB, Verweij-Van Vught AM, Peerbooms PG, Bal M, Hoitsma HF, MacLaren DM. Epidemiology of the Bacteroides fragilis group in the colonic flora in 10 patients with colonic cancer. J Med Microbiol 1989; 29: 171-176 PubMed
22 Belinkie SA, Narayanan NC, Russell JC, Becker DR. Splenic abscess associated with Streptococcus bovis septicemia and neoplastic lesions of the colon. Dis Colon Rectum 1983; 26: 823-824 PubMed
23 Kawamoto K, Teramoto T, Watanabe M, Kase S, Shatari T, Hasegawa H, Fujita S, Kuo TH, Kawano Y, Kitajima M. Splenic abscess associated with colon cancer: a case report. Jpn J Clin Oncol 1993; 23: 384-388 PubMed
24 Weathers BK, Modesto VL, Gordon D. Isolated splenic metastasis from colorectal carcinoma: report of a case and review of the literature. Dis Colon Rectum 1999; 42: 1345-1348 PubMed
25 Waller RM 3rd, Fajman WA. An unusual cause of an isolated, focal splenic defect demonstrated by liver-spleen scintigraphy. Clin Nucl Med 1982; 7: 5-7 PubMed
26 Slavin JD Jr, Mathews J, Spencer RP. Splenectomy for splenic metastasis from carcinoma of colon. Clin Nucl Med 1986; 11: 491-492 PubMed
27 Capizzi PJ, Allen KB, Amerson JR, Skandalakis JE. Isolated splenic metastasis from rectal carcinoma. South Med J 1992; 85: 1003-1005 PubMed
28 Thomas SM, Fitzgerald JB, Pollock RE, Evans DB. Isolated splenic metastases from colon carcinoma. Eur J Surg Oncol 1993; 19: 485-490 PubMed
29 Vadala G, Caragliano L, Castorina R, Caragliano V, Caragliano P. Splenic metastases. Minerva Chir 1999; 54: 273-276 PubMed
30 Lee SS, Morgenstern L, Phillips EH, Hiatt JR, Margulies DR. Splenectomy for splenic metastases: a changing clinical spectrum. Am Surg 2000; 66: 837-840 PubMed
31 Pizzirusso F, Gillet JP, Fobe D. Isolated spleen metastatic involvement from a colorectal adenocarcinoma complicated with a gastrosplenic fistula. A case report and literature review. Acta Chir Belg 2004; 104: 214-216 PubMed
S- Editor Ma N L- Editor Kerr C E- Editor Wang HF